Vicplas International Ltd. announced the appointment of Walter Tarca as Deputy Group Chief Executive Officer, with effect from 1 February 2022. Mr. Tarca has been the President of the Vicplas Medical Devices segment (Forefront Medical) since 2016 and has demonstrated excellent leadership in transforming the Medical Devices segment into the major contributor to the Vicplas Group. He will continue to work under the leadership of Mr. Cheng Liang, the Group Chief Executive Officer of the Vicplas Group during a transition period and will assume the responsibility of Group Chief Executive Officer of the Vicplas Group from the start of the next financial year beginning 1 August 2022 ("CEO Succession").

After the transition Mr. Tarca will also continue as President of the Medical Devices segment. The Nominating Committee has recommended and the Board has approved Mr. Tarca's appointment as Deputy Group Chief Executive Officer of the Vicplas Group and the CEO Succession. The NC and the Board opined that Mr. Tarca is a focused and driven leader with a deep understanding of the Vicplas businesses and the needs of Vicplas customers, employees and other stakeholders, and he is fully committed to continuing to drive sustainable long term growth for the Vicplas Group.